4.6 Article

Ribosomal protein S18 acetyltransferase RimI is responsible for the acetylation of elongation factor Tu

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 298, 期 5, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.jbc.2022.101914

关键词

-

资金

  1. Russian Science Foundation [21-64-00006]
  2. Russian Science Foundation [21-64-00006] Funding Source: Russian Science Foundation

向作者/读者索取更多资源

This study identified another key enzyme, RimI, responsible for acetylation modification in bacteria and demonstrated that acetylation of EF-Tu increases the efficiency of in vitro translation. Additionally, the absence of RimI in the strain resulted in reduced growth rate and potentially promoted conservation of the acetylation mechanism in the translation apparatus.
N-terminal acetylation is widespread in the eukaryotic proteome but in bacteria is restricted to a small number of proteins mainly involved in translation. It was long known that elongation factor Tu (EF-Tu) is N-terminally acetylated, whereas the enzyme responsible for this process was unclear. Here, we report that RimI acetyltransferase, known to modify ribosomal protein S18, is likewise responsible for N-acetylation of the EF-Tu. With the help of inducible tufA expression plasmid, we demonstrated that the acetylation does not alter the stability of EF-Tu. Binding of aminoacyl tRNA to the recombinant EF-Tu in vitro was found to be unaffected by the acetylation. At the same time, with the help of fast kinetics methods, we demonstrate that an acetylated variant of EF-Tu more efficiently accelerates A-site occupation by aminoacyltRNA, thus increasing the efficiency of in vitro translation. Finally, we show that a strain devoid of RimI has a reduced growth rate, expanded to an evolutionary timescale, and might potentially promote conservation of the acetylation mechanism of S18 and EF-Tu. This study increased our understanding of the modification of bacterial translation apparatus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据